Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.
about
Shiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic ApplicationsDo the A subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2?Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice.Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.Quiescent complement in nonhuman primates during E coli Shiga toxin-induced hemolytic uremic syndrome and thrombotic microangiopathy.Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure.Complement, thrombotic microangiopathy and disseminated intravascular coagulation.Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue.Pro-Coagulant Endothelial Dysfunction Results from EHEC Shiga Toxins and Host Damage-Associated Molecular PatternsShiga toxins expressed by human pathogenic bacteria induce immune responses in host cells.Angiotensin-(1-7) protects from brain damage induced by shiga toxin 2-producing enterohemorrhagic Escherichia coli.Shiga Toxin Therapeutics: Beyond Neutralization.Shiga Toxins Induce Apoptosis and ER Stress in Human Retinal Pigment Epithelial Cells.Modeling Hemolytic-Uremic Syndrome: In-Depth Characterization of Distinct Murine Models Reflecting Different Features of Human Disease.
P2860
Q26752966-A3F233EA-BD0E-4CC5-9677-9216365820E1Q26858938-FD70E598-47EA-43D1-A9BC-02F1B1A27189Q30300135-CE37C8E9-4C67-4696-9965-A8E0FC2D72C9Q33404640-F1A87226-7201-45DB-A97B-4953534E5A29Q33408183-FD451A9F-B23B-425F-B8F3-053016E685ECQ33415795-7E22C3CF-BFEB-4B23-AB17-C3C444C42E68Q33420624-0D4E8734-1C9A-4727-9F95-A0732C18F51FQ34889826-343B1102-55EF-46F8-8460-1FEE64A0EA0AQ35295605-DF69D7F1-7C1F-4481-8BAA-602B23CB7947Q38175364-F475988E-C93C-4836-A924-DD3B3212C747Q40524453-15090EF7-A007-44B5-8A01-965FDDC7BCF3Q41669177-3BFD3332-B3A5-4916-A644-1E7227F2E931Q44652100-2D14EFE1-26BC-4BE7-9B0B-FEB81956EB0EQ55516340-9AE96C5D-448E-4972-BB36-EAC08F610EF7
P2860
Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Distinct renal pathology and a ...... of hemolytic uremic syndrome.
@ast
Distinct renal pathology and a ...... of hemolytic uremic syndrome.
@en
type
label
Distinct renal pathology and a ...... of hemolytic uremic syndrome.
@ast
Distinct renal pathology and a ...... of hemolytic uremic syndrome.
@en
prefLabel
Distinct renal pathology and a ...... of hemolytic uremic syndrome.
@ast
Distinct renal pathology and a ...... of hemolytic uremic syndrome.
@en
P2093
P2860
P50
P1476
Distinct renal pathology and a ...... of hemolytic uremic syndrome.
@en
P2093
James Papin
Moo-Seung Lee
Rama P Cherla
Sun-Young Oh
Vernon L Tesh
P2860
P304
P356
10.1016/J.AJPATH.2012.12.026
P407
P577
2013-02-10T00:00:00Z